Guardant Health, INC Form 4 insider transactions

Co-Chief Executive Officer AmirAli Talasaz reports adjustments to performance-based restricted stock units and restricted stock units in a recent SEC filing.

Helmy Eltoukhy, Co-CEO of Guardant Health, reports the cancellation of performance-based restricted stock units and the acquisition of new restricted stock units.

Kumud Kalia, Chief Information Officer of Guardant Health, Inc., reported purchasing 2,187 shares of common stock on March 18, 2024.

Director Tariq Musa reports the vesting and conversion of restricted stock units into common stock.

Director Myrtle S. Potter reports the disposition of 68 common stock units of Guardant Health, Inc. on March 15, 2024, through the vesting of restricted stock units.

Michael Bell, CFO of Guardant Health, reports the vesting of restricted stock units and associated tax withholding.

Director Meghan Joyce reported the acquisition and disposition of Guardant Health, Inc. stock on March 4, 2024, including sales under a pre-arranged 10b5-1 plan.

John G. Saia, Chief Legal Officer of Guardant Health, Inc., reports the vesting of restricted stock units and associated tax withholding.

Amelia Merrill, SVP of People at Guardant Health, reports the vesting of restricted stock units and subsequent tax withholding.

Chief Information Officer of Guardant Health, Kumud Kalia, reports the vesting of restricted stock units and subsequent tax withholding.

Darya Chudova, Chief Technology Officer of Guardant Health, reports the vesting of restricted stock units and associated tax withholding.

Director Steve Krognes reported the vesting of restricted stock units into common stock of Guardant Health, Inc. on February 29, 2024.

Terilyn J. Monroe, Chief People Officer of Guardant Health, Inc., reports the acquisition of stock options and restricted stock units.